vs
GLOBAL INDUSTRIAL Co（GIC）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
GLOBAL INDUSTRIAL Co的季度营收约是REPLIGEN CORP的1.7倍（$345.6M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs 4.2%，领先2.5%），GLOBAL INDUSTRIAL Co同比增速更快（14.3% vs 13.6%），GLOBAL INDUSTRIAL Co自由现金流更多（$19.2M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 3.4%）
Global Industrial公司总部位于纽约州华盛顿港，核心业务是在北美地区通过品牌电商网站及关系营销渠道，向客户供应工业用品及维护、维修与运营（MRO）用品，主品牌为Global Industrial。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
GIC vs RGEN — 直观对比
营收规模更大
GIC
是对方的1.7倍
$197.9M
营收增速更快
GIC
高出0.7%
13.6%
净利率更高
RGEN
高出2.5%
4.2%
自由现金流更多
GIC
多$1.6M
$17.6M
两年增速更快
RGEN
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $345.6M | $197.9M |
| 净利润 | $14.6M | $13.3M |
| 毛利率 | 34.5% | 52.5% |
| 营业利润率 | 5.7% | 9.0% |
| 净利率 | 4.2% | 6.7% |
| 营收同比 | 14.3% | 13.6% |
| 净利润同比 | 36.4% | 143.9% |
| 每股收益（稀释后） | $0.37 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GICRGEN
| Q4 25 | $345.6M | $197.9M | ||
| Q3 25 | $353.6M | $188.8M | ||
| Q2 25 | $358.9M | $182.4M | ||
| Q1 25 | $321.0M | $169.2M | ||
| Q4 24 | $302.3M | $174.1M | ||
| Q3 24 | $342.4M | $154.9M | ||
| Q2 24 | $347.8M | $154.1M | ||
| Q1 24 | $323.4M | $151.3M |
净利润GICRGEN
| Q4 25 | $14.6M | $13.3M | ||
| Q3 25 | $18.8M | $14.9M | ||
| Q2 25 | $25.1M | $14.9M | ||
| Q1 25 | $13.6M | $5.8M | ||
| Q4 24 | $10.7M | $-30.3M | ||
| Q3 24 | $16.8M | $-654.0K | ||
| Q2 24 | $20.3M | $3.3M | ||
| Q1 24 | $13.2M | $2.1M |
毛利率GICRGEN
| Q4 25 | 34.5% | 52.5% | ||
| Q3 25 | 35.6% | 53.2% | ||
| Q2 25 | 37.1% | 50.0% | ||
| Q1 25 | 34.9% | 53.6% | ||
| Q4 24 | 33.8% | 26.1% | ||
| Q3 24 | 34.0% | 50.0% | ||
| Q2 24 | 35.2% | 49.8% | ||
| Q1 24 | 34.3% | 49.5% |
营业利润率GICRGEN
| Q4 25 | 5.7% | 9.0% | ||
| Q3 25 | 7.4% | 8.9% | ||
| Q2 25 | 9.3% | 7.6% | ||
| Q1 25 | 5.7% | 3.9% | ||
| Q4 24 | 4.8% | -17.7% | ||
| Q3 24 | 6.5% | -5.1% | ||
| Q2 24 | 7.6% | 1.0% | ||
| Q1 24 | 5.4% | 1.3% |
净利率GICRGEN
| Q4 25 | 4.2% | 6.7% | ||
| Q3 25 | 5.3% | 7.9% | ||
| Q2 25 | 7.0% | 8.2% | ||
| Q1 25 | 4.2% | 3.4% | ||
| Q4 24 | 3.5% | -17.4% | ||
| Q3 24 | 4.9% | -0.4% | ||
| Q2 24 | 5.8% | 2.2% | ||
| Q1 24 | 4.1% | 1.4% |
每股收益（稀释后）GICRGEN
| Q4 25 | $0.37 | $0.24 | ||
| Q3 25 | $0.48 | $0.26 | ||
| Q2 25 | $0.65 | $0.26 | ||
| Q1 25 | $0.35 | $0.10 | ||
| Q4 24 | $0.28 | $-0.55 | ||
| Q3 24 | $0.44 | $-0.01 | ||
| Q2 24 | $0.52 | $0.06 | ||
| Q1 24 | $0.34 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $67.5M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $313.2M | $2.1B |
| 总资产 | $580.8M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资GICRGEN
| Q4 25 | $67.5M | $767.6M | ||
| Q3 25 | $67.2M | $748.7M | ||
| Q2 25 | $55.1M | $708.9M | ||
| Q1 25 | $39.0M | $697.2M | ||
| Q4 24 | $44.6M | $757.4M | ||
| Q3 24 | $38.9M | $784.0M | ||
| Q2 24 | $38.8M | $809.1M | ||
| Q1 24 | $29.9M | $780.6M |
总债务GICRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益GICRGEN
| Q4 25 | $313.2M | $2.1B | ||
| Q3 25 | $316.0M | $2.1B | ||
| Q2 25 | $305.2M | $2.1B | ||
| Q1 25 | $287.9M | $2.0B | ||
| Q4 24 | $281.1M | $2.0B | ||
| Q3 24 | $279.2M | $2.0B | ||
| Q2 24 | $270.4M | $2.0B | ||
| Q1 24 | $260.2M | $2.0B |
总资产GICRGEN
| Q4 25 | $580.8M | $2.9B | ||
| Q3 25 | $602.5M | $2.9B | ||
| Q2 25 | $586.5M | $2.9B | ||
| Q1 25 | $536.7M | $2.9B | ||
| Q4 24 | $520.7M | $2.8B | ||
| Q3 24 | $531.6M | $2.8B | ||
| Q2 24 | $542.5M | $2.9B | ||
| Q1 24 | $517.4M | $2.8B |
负债/权益比GICRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $19.2M | $17.6M |
| 自由现金流率自由现金流/营收 | 5.6% | 8.9% |
| 资本支出强度资本支出/营收 | 0.2% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.37× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $74.7M | $93.9M |
8季度趋势，按日历期对齐
经营现金流GICRGEN
| Q4 25 | $20.0M | $25.7M | ||
| Q3 25 | $22.7M | $48.1M | ||
| Q2 25 | $31.7M | $28.6M | ||
| Q1 25 | $3.4M | $15.0M | ||
| Q4 24 | $15.9M | $39.2M | ||
| Q3 24 | $9.6M | $49.3M | ||
| Q2 24 | $18.8M | $42.2M | ||
| Q1 24 | $6.4M | $44.7M |
自由现金流GICRGEN
| Q4 25 | $19.2M | $17.6M | ||
| Q3 25 | $22.0M | $43.4M | ||
| Q2 25 | $30.3M | $21.5M | ||
| Q1 25 | $3.2M | $11.4M | ||
| Q4 24 | $15.2M | $33.6M | ||
| Q3 24 | $8.7M | $42.3M | ||
| Q2 24 | $17.9M | $37.4M | ||
| Q1 24 | $5.1M | $36.4M |
自由现金流率GICRGEN
| Q4 25 | 5.6% | 8.9% | ||
| Q3 25 | 6.2% | 23.0% | ||
| Q2 25 | 8.4% | 11.8% | ||
| Q1 25 | 1.0% | 6.8% | ||
| Q4 24 | 5.0% | 19.3% | ||
| Q3 24 | 2.5% | 27.3% | ||
| Q2 24 | 5.1% | 24.3% | ||
| Q1 24 | 1.6% | 24.0% |
资本支出强度GICRGEN
| Q4 25 | 0.2% | 4.1% | ||
| Q3 25 | 0.2% | 2.5% | ||
| Q2 25 | 0.4% | 3.9% | ||
| Q1 25 | 0.1% | 2.1% | ||
| Q4 24 | 0.2% | 3.2% | ||
| Q3 24 | 0.3% | 4.5% | ||
| Q2 24 | 0.3% | 3.1% | ||
| Q1 24 | 0.4% | 5.5% |
现金转化率GICRGEN
| Q4 25 | 1.37× | 1.93× | ||
| Q3 25 | 1.21× | 3.23× | ||
| Q2 25 | 1.26× | 1.92× | ||
| Q1 25 | 0.25× | 2.57× | ||
| Q4 24 | 1.49× | — | ||
| Q3 24 | 0.57× | — | ||
| Q2 24 | 0.93× | 12.70× | ||
| Q1 24 | 0.48× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
